| 1 |
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan A. Maertens et al. · The Lancet
|
15 Dec 2015 |
1,006 |
| 2 |
Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis
Francisco M. Marty et al. · The Lancet Infectious Diseases
|
8 Mar 2016 |
710 |
| 3 |
Identification of an antimalarial synthetic trioxolane drug development candidate
Jonathan L. Vennerstrom, Sarah Arbe‐Barnes, Reto Brun et al. · Nature
|
Aug 2004 |
624 |
| 4 |
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial
Thomas Ruzicka, Charles W Lynde, Gregor B. E. Jemec et al. · British Journal of Dermatology
|
21 Feb 2008 |
412 |
| 5 |
Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
Don Benjamin, Dimitri Robay, Sravanth Kumar Hindupur et al. · Cell Reports
Open access |
Dec 2018 |
404 |
| 6 |
Synthetic ozonide drug candidate OZ439 offers new hope for a single-dose cure of uncomplicated malaria
Susan A. Charman et al. · Proceedings of the National Academy of Sciences
Open access |
7 Feb 2011 |
383 |
| 7 |
The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization
Andrea Enrico Prota, Franck Danel, Felix Bachmann et al. · Journal of Molecular Biology
|
11 Feb 2014 |
314 |
| 8 |
mTOR Inhibitor RAD001 (Everolimus) Has Antiangiogenic/Vascular Properties Distinct from a VEGFR Tyrosine Kinase Inhibitor
Heidi A. Lane, Jeanette Marjorie Wood, Paul M.J. McSheehy et al. · Clinical Cancer Research
Open access |
17 Feb 2009 |
254 |
| 9 |
A Phase 3 Randomized Double-Blind Comparison of Ceftobiprole Medocaril Versus Ceftazidime Plus Linezolid for the Treatment of Hospital-Acquired Pneumonia
Samir Sayed Hassan Awad, Alejandro H. Rodríguez, Yin-Ching Chuang et al. · Clinical Infectious Diseases
Open access |
9 Apr 2014 |
231 |
| 10 |
In Vitro Properties of BAL30072, a Novel Siderophore Sulfactam with Activity against Multiresistant Gram-Negative Bacilli
Malcolm G. P. Page, Clothilde Dantier, Eric Desarbre · Antimicrobial Agents and Chemotherapy
Open access |
23 Mar 2010 |
227 |
| 11 |
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses
George R. Thompson, Adrián Rendón, Rodrigo Ribeiro dos Santos et al. · Clinical Infectious Diseases
Open access |
11 May 2016 |
224 |
| 12 |
In Vitro and In Vivo Properties of Ro 63-9141, a Novel Broad-Spectrum Cephalosporin with Activity against Methicillin-Resistant Staphylococci
Paul Hebeisen, Ingrid Heinze‐Krauss, Peter Angehrn et al. · Antimicrobial Agents and Chemotherapy
Open access |
Mar 2001 |
218 |
| 13 |
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data
Chiaki Tanaka, Terence O’Reilly, John M. Kovarik et al. · Journal of Clinical Oncology
|
11 Mar 2008 |
211 |
| 14 |
Results of a Double-Blind, Randomized Trial of Ceftobiprole Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria
Gary J. Noel, Richard S Strauss, Karen M. Amsler et al. · Antimicrobial Agents and Chemotherapy
Open access |
22 Oct 2007 |
191 |
| 15 |
Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
Jürg Dreier, Paolo Ruggerone · Frontiers in Microbiology
Open access |
8 Jul 2015 |
188 |
| 16 |
Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial
Bart Jan Kullberg, Claudio Viscoli, Peter G. Pappas et al. · Clinical Infectious Diseases
Open access |
4 Oct 2018 |
185 |
| 17 |
Antistaphylococcal Activity of Ceftobiprole, a New Broad-Spectrum Cephalosporin
Tatiana Bogdanovich, Lois M. Ednie, Stuart Shapiro et al. · Antimicrobial Agents and Chemotherapy
Open access |
27 Sep 2005 |
185 |
| 18 |
Single-Ascending-Dose Pharmacokinetics and Safety of the Novel Broad-Spectrum Antifungal Triazole BAL4815 after Intravenous Infusions (50, 100, and 200 Milligrams) and Oral Administrations (100, 200, and 400 Milligrams) of Its Prodrug, BAL8557, in Healthy Volunteers
Anne H. Schmitt‐Hoffmann, Brigitte Roos, Markus Heep et al. · Antimicrobial Agents and Chemotherapy
Open access |
23 Dec 2005 |
170 |
| 19 |
Binding of Ceftobiprole and Comparators to the Penicillin-Binding Proteins of Escherichia coli , Pseudomonas aeruginosa , Staphylococcus aureus , and Streptococcus pneumoniae
Todd A. Davies, Malcolm G. P. Page, Wenchi Shang et al. · Antimicrobial Agents and Chemotherapy
Open access |
30 Apr 2007 |
166 |
| 20 |
Detection of circulating tumour cell clusters in human glioblastoma
Ilona Krol, Francesc Castro-Giner, Martina Maurer et al. · British Journal of Cancer
Open access |
19 Jul 2018 |
145 |
| 21 |
Multiple-Dose Pharmacokinetics and Safety of the New Antifungal Triazole BAL4815 after Intravenous Infusion and Oral Administration of Its Prodrug, BAL8557, in Healthy Volunteers
Anne H. Schmitt‐Hoffmann, Brigitte Roos, J. Maares et al. · Antimicrobial Agents and Chemotherapy
Open access |
23 Dec 2005 |
141 |
| 22 |
Oral Alitretinoin (9-cis-Retinoic Acid) Therapy for Chronic Hand Dermatitis in Patients Refractory to Standard Therapy
Thomas Ruzicka, Frederik Grønhøj Larsen, Dorota Galewicz et al. · Archives of Dermatology
|
Dec 2004 |
135 |
| 23 |
Drug‐drug interactions between triazole antifungal agents used to treat invasive aspergillosis and immunosuppressants metabolized by cytochrome P450 3A4
Andreas H. Groll, Robert W. Townsend, Amit V. Desai et al. · Transplant Infectious Disease
Open access |
19 Jul 2017 |
134 |
| 24 |
The Burden and Impact of Vertigo: Findings from the REVERT Patient Registry
Heike Benecke, Sam Agus, Daniel Kuessner et al. · Frontiers in Neurology
Open access |
2013 |
132 |
| 25 |
Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic-Resistant Phenotypes Emerge from β-Lactamase Protein Engineering
Melissa D. Barnes, Marisa Winkler, Magdalena A. Taracila et al. · mBio
Open access |
31 Oct 2017 |
131 |
| 26 |
The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public–private partnerships for the development of new strategies to tackle antibiotic resistance
Tomislav Kostyanev, Marc J. M. Bonten, Seamus O’Brien et al. · Journal of Antimicrobial Chemotherapy
Open access |
15 Nov 2015 |
129 |
| 27 |
Impact of Specific pbp5 Mutations on Expression of β-Lactam Resistance in Enterococcus faecium
Louis B. Rice, Samuel Bellais, Lenore L. Carias et al. · Antimicrobial Agents and Chemotherapy
Open access |
23 Jul 2004 |
128 |
| 28 |
Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii
L. Moynié, Alexandre Lüscher, Dora Rolo et al. · Antimicrobial Agents and Chemotherapy
Open access |
30 Jan 2017 |
126 |
| 29 |
Prospects for the next anti-Pseudomonas drug
Malcolm G. P. Page, Jutta Heim · Current Opinion in Pharmacology
|
13 Sep 2009 |
126 |
| 30 |
NutriChip: nutrition analysis meets microfluidics
Qasem Ramadan, Hamideh Jafarpoorchekab, Chaobo Huang et al. · Lab on a Chip
Open access |
27 Nov 2012 |
123 |
| 31 |
Siderophore conjugates
Malcolm G. P. Page · Annals of the New York Academy of Sciences
|
2013 |
122 |
| 32 |
Safety and Pharmacokinetics of Isavuconazole as Antifungal Prophylaxis in Acute Myeloid Leukemia Patients with Neutropenia: Results of a Phase 2, Dose Escalation Study
Oliver A. Cornely, Angelika Böhme, Anne H. Schmitt‐Hoffmann et al. · Antimicrobial Agents and Chemotherapy
Open access |
27 Jan 2015 |
116 |
| 33 |
Ceftobiprole for Treatment of Complicated Staphylococcus aureus Bacteremia
Thomas L Holland et al. · New England Journal of Medicine
Open access |
27 Sep 2023 |
113 |
| 34 |
Pharmacokinetic Evaluation of CYP3A4‐Mediated Drug‐Drug Interactions of Isavuconazole With Rifampin, Ketoconazole, Midazolam, and Ethinyl Estradiol/Norethindrone in Healthy Adults
Robert W. Townsend, Albert G. H. Dietz, Christine Hale et al. · Clinical Pharmacology in Drug Development
Open access |
8 Jun 2016 |
113 |
| 35 |
Crystallographic and Biophysical Analysis of a Bacterial Signal Peptidase in Complex with a Lipopeptide-based Inhibitor
Mark Paetzel, Jonathon J. Goodall, Malgosia Kania et al. · Journal of Biological Chemistry
Open access |
Jul 2004 |
109 |
| 36 |
Pharmacokinetics and Pharmacodynamics of Ceftobiprole, an Anti-MRSA Cephalosporin with Broad-Spectrum Activity
Bindu Murthy, Anne H. Schmitt‐Hoffmann · Clinical Pharmacokinetics
|
2008 |
109 |
| 37 |
Structural Insights into the Anti-methicillin-resistant Staphylococcus aureus (MRSA) Activity of Ceftobiprole
Andrew L. Lovering, Michael C. Gretes, Susan S. Safadi et al. · Journal of Biological Chemistry
Open access |
20 Jul 2012 |
108 |
| 38 |
The Structure−Activity Relationship of the Antimalarial Ozonide Arterolane (OZ277)
Yuxiang Dong, Sergio Wittlin, Kamaraj Sriraghavan et al. · Journal of Medicinal Chemistry
|
19 Nov 2009 |
108 |
| 39 |
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema
Robert Bissonnette, Margitta Worm, B. Gerlach et al. · British Journal of Dermatology
|
10 Nov 2009 |
105 |
| 40 |
Single-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
Anne H. Schmitt‐Hoffmann, Brigitte Roos, Michael Schleimer et al. · Antimicrobial Agents and Chemotherapy
Open access |
23 Jun 2004 |
103 |
| 41 |
BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis
Jose Manuel Entenza, P. Hohl, Ingrid Heinze‐Krauss et al. · Antimicrobial Agents and Chemotherapy
Open access |
2002 |
91 |
| 42 |
Engineering specificity of starter unit selection by the erythromycin‐producing polyketide synthase
Paul F. Long, Christopher J. Wilkinson, Christian Bisang et al. · Molecular Microbiology
|
Mar 2002 |
90 |
| 43 |
Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system
Stefan Schwartz, Oliver A. Cornely, Kamal A. Hamed et al. · Medical Mycology
Open access |
2 Oct 2019 |
89 |
| 44 |
Antimicrobial and DNA Gyrase-Inhibitory Activities of Novel Clorobiocin Derivatives Produced by Mutasynthesis
Ute Galm, Stefanie Heller, Stuart Shapiro et al. · Antimicrobial Agents and Chemotherapy
Open access |
26 Mar 2004 |
89 |
| 45 |
Interactions of Ceftobiprole with β-Lactamases from Molecular Classes A to D
Anne Marie Queenan, Wenchi Shang, Malgosia Kania et al. · Antimicrobial Agents and Chemotherapy
Open access |
26 Jun 2007 |
87 |
| 46 |
Syrosingopine sensitizes cancer cells to killing by metformin
Don Benjamin, Marco Colombi, Sravanth Kumar Hindupur et al. · Science Advances
Open access |
2 Dec 2016 |
83 |
| 47 |
A lipid-mediated conformational switch modulates the thermosensing activity of DesK
María Eugenia Inda, Michel Vandenbranden, Ariel Fernández et al. · Proceedings of the National Academy of Sciences
Open access |
12 Feb 2014 |
82 |
| 48 |
Multiple-Dose Pharmacokinetics and Safety of a Novel Broad-Spectrum Cephalosporin (BAL5788) in Healthy Volunteers
Anne H. Schmitt‐Hoffmann, Lars Nyman, Brigitte Roos et al. · Antimicrobial Agents and Chemotherapy
|
23 Jun 2004 |
79 |
| 49 |
Involvement of the Putative ATP-Dependent Efflux Proteins PatA and PatB in Fluoroquinolone Resistance of a Multidrug-Resistant Mutant of Streptococcus pneumoniae
Estelle Marrer, Karen Schad, Andreas T. Satoh et al. · Antimicrobial Agents and Chemotherapy
Open access |
25 Jan 2006 |
79 |
| 50 |
Molecular Basis of Filtering Carbapenems by Porins from β-Lactam-resistant Clinical Strains of Escherichia coli
Harsha Bajaj, Mariano Andrea Scorciapino, L. Moynié et al. · Journal of Biological Chemistry
Open access |
9 Dec 2015 |
78 |